Epigral Limited

Epigral Limited

Epigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results.

Epigral Limited

Epigral Limited has responded to a query from the National Stock Exchange of India Limited regarding a significant increase in trading volume. The company assured that it has made all necessary disclosures as per SEBI regulations and is not connected with the movement in volume or price.

Epigral Limited

Epigral Limited has observed a significant increase in volume, prompting the NSE to write to the company for a response, ensuring investors have the latest information and safeguarding their interests.

Epigral Limited

Epigral Limited has informed the Exchange about Credit Rating- Revision, with CRISIL Ratings assigning revised ratings to the Company's bank facilities.

Epigral Limited

Epigral Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming securities received for dematerialisation during the quarter ended 30th June 2026.

Epigral Limited

Epigral Limited has informed the Exchange about the incorporation of a wholly-owned subsidiary, Epigral Advanced Materials Limited, with a paid-up capital of Rs. 1,00,000 and 10,000 equity shares of Rs. 10 each.

Epigral Limited

Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed for all Insiders, Directors, Promoters, Designated Persons, and their Immediate Relatives from 1st July, 2026, till the expiry of 48 hours after the declaration of the Un-Audited Financial Results for the First Quarter ended 30th June, 2026.